Staging of biliary tract and primary liver tumors

Surgical Oncology Clinics of North America

Volumn 23, Issue 2, 2014, Pages 313-322

  Shindoh, Junichi ^a   Vauthey, Jean Nicolas ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Bile duct cancer; Gallbladder cancer; Hepatocellular carcinoma; Intrahepatic cholangiocarcinoma; Staging

Indexed keywords

AJCC STAGING SYSTEM; BCLC STAGING SYSTEM; BILE DUCT CARCINOMA; CANCER STAGING; CLIP SCORE; GALLBLADDER CANCER; HUMAN; LCSGJ STAGING SYSTEM; LIVER CELL CARCINOMA; REVIEW; UICC STAGING SYSTEM;

BILE DUCT CANCER; GALLBLADDER CANCER; HEPATOCELLULAR CARCINOMA; INTRAHEPATIC CHOLANGIOCARCINOMA; STAGING;

BILE DUCT NEOPLASMS; HUMANS; LIVER NEOPLASMS; NEOPLASM STAGING;

EID: 84896731405     PISSN: 10553207     EISSN: 15585042     Source Type: Journal    
DOI: 10.1016/j.soc.2013.11.003     Document Type: Review

References (37)

1. The Cancer of the Liver Italian Program (CLIP) investigators Anew prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology 1998, 28:751-755.
2. The Cancer of the Liver Italian Program (CLIP) investigators Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators. Hepatology 2000, 31:840-845.
3. Levy I., Sherman M. Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto. Gut 2002, 50:881-885.
4. Ueno S., Tanabe G., Sako K., et al. Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program. Hepatology 2001, 34:529-534.
5. Okuda K., Ohtsuki T., Obata H., et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985, 56:918-928.
6. Llovet J.M., Bru C., Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999, 19:329-338.
7. Cillo U., Vitale A., Grigoletto F., et al. Prospective validation of the Barcelona Clinic Liver Cancer staging system. JHepatol 2006, 44:723-731.
8. Guglielmi A., Ruzzenente A., Pachera S., et al. Comparison of seven staging systems in cirrhotic patients with hepatocellular carcinoma in a cohort of patients who underwent radiofrequency ablation with complete response. Am J Gastroenterol 2008, 103:597-604.
9. Marrero J.A., Fontana R.J., Barrat A., et al. Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology 2005, 41:707-716.
10. Makuuchi M., Belghiti J., Belli G., et al. IHPBA concordant classification of primary liver cancer: working group report. JHepatobiliary Pancreat Surg 2003, 10:26-30.
11. Edge S., Byrd D., Campton C., et al. AJCC cancer staging manual 2010, Springer, New York. 7th edition.
12. Vauthey J.N., Lauwers G.Y., Esnaola N.F., et al. Simplified staging for hepatocellular carcinoma. JClin Oncol 2002, 20:1527-1536.
13. Cheng C.H., Lee C.F., Wu T.H., et al. Evaluation of the new AJCC staging system for resectable hepatocellular carcinoma. World J Surg Oncol 2011, 9:114.
14. Kee K.M., Wang J.H., Lee C.M., et al. Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: analysis of 5,613 cases from a medical center in southern Taiwan. Int J Cancer 2007, 120:2650-2655.
15. Lei H.J., Chau G.Y., Lui W.Y., et al. Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma. JAm Coll Surg 2006, 203:426-435.
16. Poon R.T., Fan S.T. Evaluation of the new AJCC/UICC staging system for hepatocellular carcinoma after hepatic resection in Chinese patients. Surg Oncol Clin N Am 2003, 12:35-50. viii.
17. Ramacciato G., Mercantini P., Cautero N., et al. Prognostic evaluation of the new American Joint Committee on Cancer/International Union Against Cancer staging system for hepatocellular carcinoma: analysis of 112 cirrhotic patients resected for hepatocellular carcinoma. Ann Surg Oncol 2005, 12:289-297.
18. Varotti G., Ramacciato G., Ercolani G., et al. Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients. Eur J Surg Oncol 2005, 31:760-767.
19. Wu C.C., Cheng S.B., Ho W.M., et al. Liver resection for hepatocellular carcinoma in patients with cirrhosis. Br J Surg 2005, 92:348-355.
20. Vauthey J.N., Ribero D., Abdalla E.K., et al. Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment. JAm Coll Surg 2007, 204:1016-1027.
21. Arii S., Yamaoka Y., Futagawa S., et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 2000, 32:1224-1229.
22. Inoue K., Takayama T., Higaki T., et al. Clinical significance of early hepatocellular carcinoma. Liver Transpl 2004, 10:S16-S19.
23. Livraghi T., Meloni F., Di Stasi M., et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice?. Hepatology 2008, 47:82-89.
24. Takayama T., Makuuchi M., Hirohashi S., et al. Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology 1998, 28:1241-1246.
25. Todo S., Furukawa H. Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg 2004, 240:451-459. [discussion: 59-61].
26. Yamashita Y., Tsuijita E., Takeishi K., et al. Predictors for microinvasion of small hepatocellular carcinoma
27. Jonas S., Bechstein W.O., Steinmuller T., et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001, 33:1080-1086.
28. Liver Cancer Study Group of Japan Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 1990, 211:277-287.
29. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. NEngl J Med 1996, 334:693-699.
30. Belghiti J., Cortes A., Abdalla E.K., et al. Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg 2003, 238:885-892.
31. Sala M., Fuster J., Llovet J.M., et al. High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation. Liver Transpl 2004, 10:1294-1300.
32. Kaczynski J., Hansson G., Wallerstedt S. Incidence, etiologic aspects and clinicopathologic features in intrahepatic cholangiocellular carcinoma-a study of 51 cases from a low-endemicity area. Acta Oncol 1998, 37:77-83.
33. Nathan H., Aloia T.A., Vauthey J.N., et al. Aproposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol 2009, 16:14-22.
34. de Jong M.C., Nathan H., Sotiropoulos G.C., et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. JClin Oncol 2011, 29:3140-3145.
35. Farges O., Fuks D., Le Treut Y.P., et al. AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: by the AFC-IHCC-2009 study group. Cancer 2011, 117:2170-2177.
36. Bismuth H., Corlette M.B. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 1975, 140:170-178.
37. Kokudo N., Makuuchi M., Natori T., et al. Strategies for surgical treatment of gallbladder carcinoma based on information available before resection. Arch Surg 2003, 138:741-750.